Submitted by Anonymous (not verified) on 22 October 2025 - 11:20
Human medicines European public assessment report (EPAR): Zonisamide Viatris (previously Zonisamide Mylan), zonisamide, Date of authorisation: 31/03/2016, Revision: 13, Status: Authorised
Source: